Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. Guo M, Chan THM, Zhou Q, An O, et al. Blood 2023;141:3078-3090.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo M, Chan THM, Zhou Q, An O, et al. Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. Blood 2023;141:3078-3090.
PMID: 36796022